Company intelligence / Profile preview

Phenox

Bochum, North Rhine-Westphalia, Germanyphenox.net ↗

Ownership: Private
Employees: ~250
Development stage: Commercial

Overview

Phenox develops and markets innovative medical devices for the treatment of acute ischemic stroke and intracranial aneurysms. Their products are CE-marked and used clinically in Europe and other regions. The company has established a strong presence in neurointerventional therapy with several commercialized products.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

3 assets

pRESET

Commercial

Indications: Ischemic stroke

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Phenox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phenox.

Explore the full profile